UK pharmaceutical organisation calls for Government to act on parallel trading to maintain reliable drug supplies

GSK has been forced to defend criticism of its controversial diabetes drug Avandia from prominent organisations in the healthcare industry

A partnership led by Novartis has developed a new antimalarial drug candidate offering a novel way to treat strains of the disease resistant to current drugs

The University of Manchester's Intellectual Property commercialisation company is to co-develop a novel treatment for bone diseases

The ideal treatment for venous thromboembolism does not exist, but progress is being made

Editors of the New England Journal of Medicine have suggested that the US Food and Drug Administration pull Abbott's Meridia due to health risks

Allergan has agreed to pay $600m as part of a settlement over the company's US marketing practices related to Botox

The US FDA has issued a safety warning to remind healthcare professionals of the increased mortality risk associated with antibacterial Tygacil

Eli Lilly has won a court victory that the company said will keep osteoporosis drug Evista protected from generic competition in the US until 2014

The European Commission has granted Archimedes Pharma marketing authorisation for PecFent, a nasal spray for breakthrough cancer pain in adults

The European Commission has approved AstraZeneca's Seroquel XR as an add-on treatment for major depressive disorder

Takeda and Orexigen have entered into a partnership to commercialise investigational obesity drug Contrave in North America

Abbott and Roche lead the pack for rheumatologists in the latest medeConnect survey

Pfizer has announced it is to acquire FoldRx Pharmaceuticals, a privately held drug discovery and clinical development company

Medical communications and drug development consultancy, Prism Ideas, has appointed Nigel Brooksby as non-executive chairman

The EMIG Steering Group has obtained approved membership of EUCOPE

The US Food and Drug Administration has delayed the decision date of the marketing application for GSK's experimental epilepsy drug ezogabine

The US Food and Drug Administration has granted orphan drug status to BioMarin Pharmaceutical's investigational therapy for Pompe disease

Harry Armfield, joint creative director of Lane Earl Cox (LEC), overcomes his instinctive Luddite leanings to embrace 'digitalology'

The US FDA has granted priority review for Boehringer Ingelheim's dabigatran etexilate for the prevention of stroke in patients with atrial fibrillation